LumiThera, Inc. logo

LumiThera, Inc.

gritt.io

LumiThera develops light-based photobiomodulation devices for ophthalmology, including the Valeda Light Delivery System for people with dry age-related macular degeneration. Its devices are intended to help improve vision and slow vision loss.

Facts

HQ
Poulsbo, WA, US
Sectors
Medical devices, Healthcare, Ophthalmology
Stage
Series C
Members see funding amounts.
.

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about LumiThera, Inc.

See all 5

LumiThera raises $1.15M to advance Valeda photobiomodulation device for dry AMD, in U.S. trials and EU‑approved

LumiThera raised $1.15 million to advance its Valeda Light Delivery System, a photobiomodulation device aimed at improving and slowing vision loss in patients with dry age-related macular degeneration that is in U.S. clinical trials and approved for sale in the EU. The Poulsbo, Washington startup, co‑founded and led by CEO Clark Tedford, lists investors including Keiretsu Forum Northwest and executives with medical-device experience on its leadership team.

Online

Questions about LumiThera, Inc.

What is LumiThera, Inc.?

gritt.io

Who invested in LumiThera, Inc., and how much has it raised?

Members of Seattle Flow see LumiThera, Inc.'s funding rounds, amounts and investors on its Funding tab. Joining is free.

Where is LumiThera, Inc. based?

LumiThera, Inc. is headquartered in Poulsbo, WA, US.